Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05510895
Title Neoadjuvant Encorafenib, Binimetinib and Cetuximab for Patients With BRAF V600E Mutated/pMMR Localized Colorectal Cancer (NeoBRAF)
Acronym NeoBRAF
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AIO-Studien-gGmbH
Age Groups: adult | senior
Covered Countries DEU

Additional content available in CKB BOOST